Phase 3 trial data confirm efficacy and safety profile of R21/Matrix-M malaria vaccine in African… EP News Bureau Feb 2, 2024 Investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78 per…
